<?xml version="1.0" encoding="UTF-8"?>
<fig id="F3" orientation="portrait" position="float">
 <label>Figure 3</label>
 <caption>
  <p>Homeostasis of RAS-ACE2 under normal healthy conditions
   <xref rid="R10" ref-type="bibr">10 19</xref>; perturbation of RAS-ACE2 homeostasis in cardiovascular disease, hypertension and diabetes mellitus
   <xref rid="R22" ref-type="bibr">22 27</xref>; COVID-19 may potentially further upregulate RAS in CVD patients and deplete ACE2
   <xref rid="R33" ref-type="bibr">33</xref>; proposition that rhACE2 replacement therapy improves RAS-ACE2 balance by augmenting ACE2 and decreasing RAS activation.
   <xref rid="R37" ref-type="bibr">37</xref> CVD, cardiovascular disease; HTN, hypertension; DM, diabetes mellitus; RAS, renin angiotensin system; rhACE2, recombinanthuman ACE2.
  </p>
 </caption>
 <graphic xlink:href="openhrt-2020-001302f03" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
